The second site is lateral to the first over the occipital groove (this is a palpable groove)
At Intra-V, we base recommendations on: your health history your goals medications and risk factors and when appropriate, lab work Important note: Peptide therapy is personalized
In a 64-week trial enrolling 307 overweight adults, oral semaglutide 25 mg once daily caused an average weight loss of 13.6% compared to 2.2% with placebo
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome
Patients who should not use these medications include those with a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, severe gastroparesis, or active eating disorders